CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Salix, A Division of Valeant Pharmaceuticals North America, LLC.
Target Audience: The target audience for this activity is gastroenterologists and other health care professionals involved in the treatment of patients with ulcerative colitis.
Learning Objective: Upon successful completion of this activity, participants should be better able to:
- Differentiate available and emerging therapies for the management of ulcerative colitis based on mechanism of action, efficacy, safety, and recommended usage.
- Apply knowledge of mechanisms of action, efficacy, safety, and recommended usage of available agents for ulcerative colitis management to clinical decision-making.
- Utilize appropriate prognostic indicators and disease activity assessment to individualize therapy for patients with ulcerative colitis.
- Review the clinical significance of early disease detection and treatment as well as effective therapeutic strategies for difficult-to-treat patients with ulcerative colitis, including those who are refractory to conventional treatment or have limited access to care.
Activity Chair:
William J. Sandborn, MD
Professor of Medicine and Adjunct Professor of Surgery
Chief, Division of Gastroenterology
Director, UCSD IBD Center
University of California San Diego and UC San Diego Health System
La Jolla, CA
Faculty:
Stephen B. Hanauer, MD
Clifford Joseph Barborka Professor of Medicine
Northwestern University Feinberg School of Medicine
Medical Director, Digestive Health Center
Chicago, IL
Uma Mahadevan, MD
Associate Professor of Medicine
Co-Medical Director, UCSF Center for Colitis and Crohn's Disease
University of California, San Francisco
San Francisco, CA
David T. Rubin, MD
Professor of Medicine
University of Chicago Medicine
Chicago, IL
Reviewers:
Julia B. Greer MD, MPH
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 12/9/2016)
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material was originally approved for 1 year from the date of original release, December 8, 2015 through December 7, 2016. It has since been recertified for an additional year and will now expire on December 9, 2017.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must watch the presentation and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 2 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity chair reports the following relationship(s):
William J. Sandborn, MD
Consulting Fee: AbbVie, Actavis, Amgen, Genentech, Janssen, Pfizer, Prometheus, Receptos, Salix, Santarus, Shire, Takeda, UCB Pharma
Speakers Bureau: Takeda
Contracted Research: AbbVie, Amgen, Genentech, Janssen, Pfizer, Prometheus, Receptos, Takeda
Stephen B. Hanauer, MD
Consulting Fee: AbbVie, Actavis, Amgen, Celltrion, Ferring, Hospira, Janssen, Lilly, Pfizer, Prometheus, Receptos, Salix, Seres Health, Shire, Takeda, UCB Pharma
Speakers Bureau: AbbVie, Janssen, Takeda
Contracted Research (paid to institution): AbbVie, Amgen, Janssen, Lilly, Pfizer, Prometheus, Receptos, Takeda, UCB Pharma
Uma Mahadevan, MD
Consulting Fee: AbbVie, Celgene, Janssen, Takeda, UCB Pharma
Contracted Research: Millennium, Prometheus, UCB Pharma
David T. Rubin, MD
Consulting Fee: AbbVie, Amgen, Emmi, Genentech, Janssen, Pfizer, Prometheus, Shire, Takeda, UCB Pharma
Contracted Research: AbbVie, Genentech, Janssen, Prometheus, Shire, Takeda, UCB Pharma
Co-Founder: Cornerstones Health, Inc.
Board of Trustees: American College of Gastroenterology
Reviewers report the following relationship(s):
Julia B. Greer MD, MPH
No relevant financial relationships to disclose.
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at CME@VindicoCME.com